These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36816734)

  • 1. Can clinicopathologic high-risk features in T3N0 colon cancer be reliable prognostic factors?
    Lee HG; Kim YI; Park IJ; Lim SB; Yu CS
    Ann Surg Treat Res; 2023 Feb; 104(2):109-118. PubMed ID: 36816734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Reliability of Lymphovascular Invasion for Patients with T3N0 Colorectal Cancer in Adjuvant Chemotherapy Decision Making.
    Lee H; Yoo SY; Park IJ; Hong SM; Lim SB; Yu CS; Kim JC
    Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal.
    Babcock BD; Aljehani MA; Jabo B; Choi AH; Morgan JW; Selleck MJ; Luca F; Raskin E; Reeves ME; Garberoglio CA; Lum SS; Senthil M
    Ann Surg Oncol; 2018 Jul; 25(7):1980-1985. PubMed ID: 29675762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion.
    Metcalfe MJ; Ferguson JE; Li R; Xiao L; Guo CC; Czerniak BA; Siefker-Radtke A; Pretzsch SM; Navai N; McConkey DJ; Kamat AM; Campbell M; Dinney C
    Eur Urol Focus; 2017 Dec; 3(6):577-583. PubMed ID: 28753816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study based on SEER database: not all high-risk factors are equal for stage II colon cancer.
    Li D; Jiang Z; Xiang L; Yang C; Long F; Liu W
    Transl Cancer Res; 2022 Apr; 11(4):689-698. PubMed ID: 35571652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of perineural and lymphovascular invasion in locally advanced rectal cancer treated by preoperative chemoradiotherapy and radical surgery: Can perineural invasion be an indication of adjuvant chemotherapy?
    Song JH; Yu M; Kang KM; Lee JH; Kim SH; Nam TK; Jeong JU; Jang HS; Lee JW; Jung JH
    Radiother Oncol; 2019 Apr; 133():125-131. PubMed ID: 30935568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omission of Adjuvant Chemotherapy Is Associated With Increased Mortality in Patients With T3N0 Colon Cancer With Inadequate Lymph Node Harvest.
    Wells KO; Hawkins AT; Krishnamurthy DM; Dharmarajan S; Glasgow SC; Hunt SR; Mutch MG; Wise P; Silviera ML
    Dis Colon Rectum; 2017 Jan; 60(1):15-21. PubMed ID: 27926553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversial Issues Regarding Obligatory Adjuvant Chemotherapy for Stage IIIA Colon Cancer.
    Kim CW; Kim TW; Lee JL; Park IJ; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2020 Dec; 19(4):e157-e163. PubMed ID: 32896486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients.
    Zhang L; Deng Y; Liu S; Zhang W; Hong Z; Lu Z; Pan Z; Wu X; Peng J
    BMC Cancer; 2023 Jan; 23(1):3. PubMed ID: 36593480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CA19-9 is a prognostic factor in pT3N0 gastric cancer patients undergoing curative resection.
    Maruyama T; Akashi Y; Hakoda H; Sako A; Ueda K; Kato S; Azuma K; Kaneko Y; Ikeguchi A; Nagai S; Oda T
    Langenbecks Arch Surg; 2022 Sep; 407(6):2273-2279. PubMed ID: 35551467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: a multi-institutional analysis.
    Ejaz A; Casadaban L; Maker AV
    J Surg Res; 2017 Jul; 215():12-20. PubMed ID: 28688636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence-Free Survival Outcomes Based on Novel Classification Combining Lymphovascular Invasion, Perineural Invasion, and T4 Status in Stage II-III Colon Cancer.
    Kang JH; Son IT; Kim BC; Park JH; Kim JY; Kim JW
    Cancer Manag Res; 2022; 14():2031-2040. PubMed ID: 35757161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.
    Grande R; Corsi D; Mancini R; Gemma D; Ciancola F; Sperduti I; Rossi L; Fabbri A; Diodoro MG; Ruggeri E; Zampa G; Bianchetti S; Gamucci T
    PLoS One; 2013; 8(12):e80188. PubMed ID: 24339871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for locoregional recurrence in patients with pathologic T3N0 rectal cancer with negative resection margin treated by surgery alone.
    Baek JY; Yu JI; Park HC; Choi DH; Yoo GS; Cho WK; Lee WY; Yun SH; Cho YB; Park YA; Kim HC
    Radiat Oncol J; 2019 Jun; 37(2):110-116. PubMed ID: 31266292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 19. Pattern of Use of Adjuvant Chemotherapy for Stage II Colon Cancer: A Single-Institution Experience.
    Osarogiagbon RU; Sachdev JC; Khattak AG; Kronish LE
    Clin Colorectal Cancer; 2009 Mar; 8(2):94-9. PubMed ID: 19423502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of use of adjuvant chemotherapy for stage II colon cancer: a single-institution experience.
    Osarogiagbon RU; Sachdev JC; Khattak AG; Kronish LE
    Clin Colorectal Cancer; 2009 Apr; 8(2):94-9. PubMed ID: 19739270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.